Serial Number
97194534
Owner
Caris Science, Inc.Attorney
Anne FleesonFirst Use Date
Apr 1, 2011
Filing Date
Dec 29, 2021
CARIS Trademark
Serial Number: 97194534 • Registration: 7394736
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Anne Fleeson WOMBLE BOND DICKINSON (US) LLP
ONE WEST FOURTH STREET
WINSTON-SALEM, NC 27101
UNITED STATES
Trademark Details
Filing Date
December 29, 2021
Registration Date
May 28, 2024
First Use Anywhere
April 1, 2011
First Use in Commerce
April 1, 2011
Published for Opposition
March 12, 2024
Goods & Services
Medical research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, cellular manipulation, light microscopic examination, immunohistochemistry flow cytometry, expression profiling, microarray analysis, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing temporary use of online, nondownloadable software for tracking laboratory information featuring customized biospecimens and coordinating and conducting follow-on studies to complement the clinical findings; medical and scientific research; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient history reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, prognosis, and predicting or monitoring therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for medical research purposes